Scheme of arrangement effective (9036Q)
October 26 2011 - 9:32AM
UK Regulatory
TIDMASTR TIDMEVOL
RNS Number : 9036Q
Astaire Group Plc
26 October 2011
Astaire Group PLC
Scheme of Arrangement
to cancel all the issued Astaire Shares not held by
Evolve Capital PLC
Scheme Effective
For immediate release
26 October 2011
The Directors of Astaire Group PLC ("Astaire") and Evolve
Capital PLC ("Evolve") are pleased to announce that the Scheme of
Arrangement to cancel all the issued Astaire Ordinary Shares other
than those held by Evolve Capital PLC is now effective.
Under the Scheme, Astaire Shareholders may elect to receive
consideration of 2p per Astaire Ordinary Share in cash, failing
which they will receive 7 New Evolve Shares for every 5 Astaire
Ordinary Shares held if all the conditions of the Scheme are
satisfied. Following the Court Order being filed at Companies House
earlier today all conditions of the Scheme have now been satisfied
and Astaire will become a wholly owned subsidiary of Evolve.
Dealings in Astaire Ordinary Shares on AIM were suspended this
morning and will be cancelled at 7.30 a.m. tomorrow.
Valid elections to receive the Cash Alternative, which closed on
25 October 2011, have been received in respect of 78,906,023
Astaire Ordinary Shares in addition to which overseas shareholders
in certain Restricted Jurisdictions holding 933,095 Astaire
Ordinary Shares will receive cash consideration. The total cash
consideration which amounts to GBP1,596,782.36 will be paid to
those Astaire Shareholders entitled to it by 10 November 2011.
21,563,454 New Evolve Shares have been allotted (subject to the
Scheme becoming effective and Admission) to Astaire Shareholders in
respect of 15,402,790 Astaire Ordinary Shares in respect of which
no valid elections for the Cash Alternative have been received.
The issue of the New Evolve Shares will result in there being
304,919,553 Evolve Shares in issue. There are no Evolve Shares held
in treasury. Therefore, the total number of Evolve Shares with
voting rights is 304,919,553.
The above figure of 304,919,553 Evolve Shares may be used by
shareholders in Evolve as the denominator for the calculations by
which they will determine if they are required to notify their
interest in, or a change in their interest in, the share capital of
the Company under the FSA's Disclosure and Transparency Rules.
Application has been made for the New Evolve Shares to be
admitted to trading on AIM and dealings in the New Evolve Shares
are expected to commence at 8.00 a.m. tomorrow, 27 October
2011.
The CREST accounts of Astaire Shareholders who held their
Astaire Ordinary Shares in CREST will be credited with any New
Evolve Shares to which they are entitled on or around 27 October
2011. Certificates for New Evolve Shares will be sent to Astaire
Shareholders who held their Astaire Ordinary Shares in certificated
form by 10 November 2011.
Enquiries:
Astaire Group Plc Tel: 020 7492 4757
Chris Roberts, Finance Director
Fairfax I.S. PLC
Nominated Adviser/Broker to Astaire Group Plc Tel: 020 7598 5368
David Floyd/Katy Birkin
Evolve Capital plc Tel: 020 7937 4445
Oliver Vaughan, Chairman
Allenby Capital Limited Tel: 020 3328 5656
Nominated Adviser/Broker to Evolve Capital plc
Nick Naylor/Nick Athanas
A copy of this announcement, the Scheme Document and certain
information published or otherwise made available by Astaire in
connection with the recommended Scheme is available at:
http://www.astairegroup.co.uk. A copy of this announcement, the
Scheme Document and certain information published or otherwise made
available by Evolve in connection with the recommended Scheme is
also available on Evolve's website at www.evolvecapital.co.uk.
Words and expressions used in this announcement have the same
meanings as in the Scheme Document unless the contaxt requires
otherwise.
Fairfax, which is authorised and regulated in the United Kingdom
by the Financial Services Authority, is acting exclusively for
Astaire and no one else in connection with the Scheme and will not
be responsible to anyone other than Astaire for providing the
protections afforded to customers of Fairfax or for providing
advice in relation to the Scheme or any other matter referred to
herein.
Allenby, which is authorised and regulated in the United Kingdom
by the Financial Services Authority, is acting exclusively for
Evolve and no one else in connection with the Scheme and will not
be responsible to anyone other than Evolve for providing the
protections afforded to customers of Evolve or for providing advice
in relation to the Scheme or any other matter referred to
herein.
This Announcement does not constitute, or form part of, an offer
or invitation to purchase any securities.
The persons responsible for this joint announcement are the
directors of Astaire and of Evolve. To the best of the knowledge
and belief of the Directors of Astaire and of Evolve, the
information in this announcement is in accordance with the facts
and does not omit anything likely to affect the import of such
information.
This information is provided by RNS
The company news service from the London Stock Exchange
END
SOAPGGUWUUPGGCQ
Astaire Group (LSE:ASTR)
Historical Stock Chart
From Oct 2024 to Nov 2024
Astaire Group (LSE:ASTR)
Historical Stock Chart
From Nov 2023 to Nov 2024